Clinical Trials Browser

Withdrawn × OTHER × Biliary Tract Neoplasms × Clear all

Tertiary Lymphoid Structures, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Sarcoma, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT06017297 2024-11-12

ESR-22-21719

Phase 2 Withdrawn

Gastrointestinal

Biliary Tract Neoplasms

NCT03110510 2022-06-15

FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study

Phase 2 Withdrawn

Gastrointestinal

Biliary Tract Neoplasms

NCT04480190 2022-04-20

Neoadjuvant Therapy in Biliary Adenocarcinoma

Phase 1 Withdrawn

Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT03419247 2021-04-01

Molecular Profiling of Advanced Biliary Tract Cancers

Phase NA Withdrawn

Gastrointestinal

Biliary Tract Neoplasms

NCT03129074 2018-05-23

Study of Varlitinib Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer

Phase 2 Withdrawn

Gastrointestinal

Biliary Tract Neoplasms

NCT02720601 2018-01-25

Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers

Phase 2 Withdrawn

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms

NCT00487851 2013-04-12

Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-resectable Periampullary Cancer

Phase 2 Withdrawn

Gastrointestinal

Biliary Tract Neoplasms, Bites and Stings, Duodenal Neoplasms, Jaundice, Neoplasms, Pancreatic Neoplasms

Clinical Trials

EMPIRE

ESR-22-21719

FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study

Neoadjuvant Therapy in Biliary Adenocarcinoma

Molecular Profiling of Advanced Biliary Tract Cancers

Study of Varlitinib Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer

Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers

Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-resectable Periampullary Cancer